Thursday, July 30, 2015

Actor Charleton Heston once said, "...from my cold dead hands."

This 10 year old boy got prosthetic feet and 2 hand transplants. He lost his original from sepsis.

www.wallstreetdaily.com/2015/07/30/zion-harvey-double-hand-transplant/


As of July 29 eyeballing the Celgene stock price chart in january it was hovering in the 110-120 range. it is now in the 130-140 range (132.14). Like all stocks it has gone up and down based on the demands of consumers both buyers and sellers. After all in order to buy something, there must be a seller. Even if the company is the seller when it creates stock shares (ex. increasing the number of stocks due to stock option creation). So in this case those who agreed with the CNBC reported opinion to have Celgene stock were rewarded for the risk of owning it. 
From http://www.thestreet.com/quote/CELG.html
"CELG Performance as of Prev. Close
YTD

21.06%
3-Mo

19.29%"

Wednesday, July 29, 2015


Americans will still have to get a rx to buy statins. Neither Mevavor (in years past), nor Lipitor were given FDA permission to become OTC. Can't blame the manufacturers for trying (in different years), but in school one concept brought up was,"Where is the inexpensive OTC lab service to do periodic monitoring?
Granted it would be awesome if a patient could get lab services while waiting on a statin purchase, but often labs are expensive to set up.
Additional worries were probably: Is it normal muscle soreness or is it Rhabdomyolysis? Can we not mix statins and other OTCs? What about the statin-marijuana-alcohol combination?" 
For better or for worse, the FDA does not wish it. So let it be written, so let it be done.

From the peer reviewed literature below on the differences of US versus UK government opinion of statins.

Source:
http://www.fiercepharma.com/story/pfizer-drops-effort-make-lipitor-otc-med/2015-07-29?utm_campaign=AddThis&utm_medium=AddThis&utm_source=twitter#.VbkVxCOC2Pg.twitter

Those in the UK can get simvastatin OTC, but only after consulting with a RPH.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC558157/


Sunday, July 26, 2015

Geriatric RPH news....

Brian J. Isetts, RPh, PhD, BCPS, FAPhA will be the Lamy Lecturer for #AM15.  (Note, people below are not the said RPH).





Twitter on antibiotics.....



Saturday, July 25, 2015

www.washingtonpost.com/blogs/wonkblog/wp/2015/07/24/anthem-to-buy-cigna-to-create-new-health-insurance-giant/

"A merged company would serve 53 million people and is part of a dramatic , long- predicted reshaping of the health insurance landscape, from five big players to three. The new company is projected to generate $ 115 billion in annual revenues . Its competitors include UnitedHealth Group, which has more than 45 million members , and Aetna and Humana, which announced they would merge in July, creating a company serving 33 million people.
While the major trend of consolidation is the same in these big health care deals, analysts said there are key differences between them. Aetna' s deal to buy Humana greatly expanded its presence in the Medicare Advantage marketplace, whereas the Cigna and Anthem merger will have the biggest ripple effects for the commercial insurance market, where both companies are already major players."


Friday, July 24, 2015

Have hepatitis?

www.txliver.com/hepatitis-support-group/

Refreshments Provided Please RSVP by calling toll free: 855.437.2267 Sponsor: AcariaHealth

No free travel provided.